Shiwei Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shiwei Liu has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Cong-Yi Wang
Department of Respiratory and Critical Care Medicine, the Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
7 shared publications Fei Sun
Department of Respiratory and Critical Care Medicine, the Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5 shared publicationsFei Xiong
Department of Respiratory and Critical Care Medicine, the Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4 shared publicationsLongmin Chen
Department of Respiratory and Critical Care Medicine, the Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4 shared publicationsPing Yang
Department of Respiratory and Critical Care Medicine, the Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4 shared publicationsQianqian Xu
Department of Respiratory and Critical Care Medicine, the Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4 shared publications
Latest Publications
- Open Access
- 28 January 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1) , 145
Correction: Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation
- 28 January 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1) , 145
Open AccessCorrection: Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation
- Open Access
- 9 December 2025
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 18 (1)
Unveiling the role of angiogenesis-related biomarkers in diabetic nephropathy via transcriptomics
Diabetic nephropathy (DN), a common complication of diabetes, is characterized by structural and functional renal damage. Angiogenesis plays a pivotal role
- 9 December 2025
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 18 (1)
Open AccessUnveiling the role of angiogenesis-related biomarkers in diabetic nephropathy via transcriptomics
Diabetic nephropathy (DN), a common complication of diabetes, is characterized by structural and functional renal damage. Angiogenesis plays a pivotal role
- Open Access
- 1 October 2025
- Published by Tsinghua University Press in Tsinghua Science and Technology
- Vol. 32 (1) , 549-561
A physics-informed glucose-insulin neural network model for glucose prediction
Accurate glucose prediction plays an important role in glucose management and closed-loop insulin delivery for subjects with diabetes. Due to its powerful data mining capability, neural networks are used to grasp the glucose trends from continuous glucose monitoring (CGM) data. However, this approach requires a large number of individual data and plentiful computing resources, but has relatively poor interpretability. Given that the glucose metabolism mechanism model contains abundant physiological information, fusing the information with neural networks can reduce the demand for data and computing resources, and improve interpretability. In this study, a physics-informed glucose-insulin neural network (PIGNN) model is proposed, of which the structure and loss function are designed based on the glucose-insulin dynamic model. According to the experiments of 22 real subjects and 30 in-silico subjects with type 1 diabetes, the prediction accuracy of this method achieves 0.726 ± 0.126 mmol/L. Compared with models without physical information, the proposed PIGNN shows a significant improvement in glucose prediction for real subjects with a limited sample size (only 48 data samples), resulting in an accuracy improvement of 12.33%. In addition, it is proved that with limited data more physical information can improve the glucose prediction accuracy significantly.
- 1 October 2025
- Published by Tsinghua University Press in Tsinghua Science and Technology
- Vol. 32 (1) , 549-561
Open AccessA physics-informed glucose-insulin neural network model for glucose prediction
Accurate glucose prediction plays an important role in glucose management and closed-loop insulin delivery for subjects with diabetes. Due to its powerful data mining capability, neural networks are used to grasp the glucose trends from continuous glucose monitoring (CGM) data. However, this approach requires a large number of individual data and plentiful computing resources, but has relatively poor interpretability. Given that the glucose metabolism mechanism model contains abundant physiological information, fusing the information with neural networks can reduce the demand for data and computing resources, and improve interpretability. In this study, a physics-informed glucose-insulin neural network (PIGNN) model is proposed, of which the structure and loss function are designed based on the glucose-insulin dynamic model. According to the experiments of 22 real subjects and 30 in-silico subjects with type 1 diabetes, the prediction accuracy of this method achieves 0.726 ± 0.126 mmol/L. Compared with models without physical information, the proposed PIGNN shows a significant improvement in glucose prediction for real subjects with a limited sample size (only 48 data samples), resulting in an accuracy improvement of 12.33%. In addition, it is proved that with limited data more physical information can improve the glucose prediction accuracy significantly.
- Open Access
- 22 August 2025
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 21 (12) , 5428-5443
WTAP Maintains Alternative Activation of Macrophages by Promoting IDH1-Mediated α-ketoglutarate Production
Background: N6-methyladenosine (m6A) modification plays a crucial role in various physiological processes by regulating mRNA biology. However, the exact impact of m6A modification on macrophages in adipose tissues under obese settings remains to be further elucidated.
- 22 August 2025
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 21 (12) , 5428-5443
Open AccessWTAP Maintains Alternative Activation of Macrophages by Promoting IDH1-Mediated α-ketoglutarate Production
Background: N6-methyladenosine (m6A) modification plays a crucial role in various physiological processes by regulating mRNA biology. However, the exact impact of m6A modification on macrophages in adipose tissues under obese settings remains to be further elucidated.
- 15 April 2025
- Published by Elsevier in Canadian Journal of Diabetes
- Vol. 49 (5-6) , 294-301.e5
Association Between Circulating Vitamin C Concentrations and Risk of Diabetes Mellitus: Dual Evidence From NHANES Database and Mendelian Randomization Analysis
- 15 April 2025
- Published by Elsevier in Canadian Journal of Diabetes
- Vol. 49 (5-6) , 294-301.e5
Association Between Circulating Vitamin C Concentrations and Risk of Diabetes Mellitus: Dual Evidence From NHANES Database and Mendelian Randomization Analysis
- Open Access
- 20 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-22
Adipose progenitor cell-derived extracellular vesicles suppress macrophage M1 program to alleviate midlife obesity
Among different age groups, middle-aged individuals are particularly susceptible to obesity, with a 22% higher risk of all-cause mortality. However, the underlying mechanisms remain unclear. In this study, we identify adipose progenitor cells (APCs) in the white adipose tissue (WAT) of middle-aged subjects as potential causes of midlife obesity. Specifically, the extracellular vesicles (EVs) derived from APCs display an impaired ability to mitigate the inflammaging of adipose tissue macrophages (ATMs) in middle-aged individuals. Mechanistically, these EVs, lacking miR-145-5p, fail to suppress the expression of L-selectin in ATMs, thereby facilitating their M1 program via the NF-κB signaling pathway. In contrast, EVs from young APCs effectively inhibit M1 macrophage polarization. Accordingly, targeted liposomes are designed to deliver miR-145-5p mimics to ATMs, which effectively prevent the obesity in middle-aged mice. Collectively, our findings highlight the role of APC-derived EVs in midlife obesity and propose miR-145-5pas a promising therapeutic target for clinical applications.
- 20 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-22
Open AccessAdipose progenitor cell-derived extracellular vesicles suppress macrophage M1 program to alleviate midlife obesity
Among different age groups, middle-aged individuals are particularly susceptible to obesity, with a 22% higher risk of all-cause mortality. However, the underlying mechanisms remain unclear. In this study, we identify adipose progenitor cells (APCs) in the white adipose tissue (WAT) of middle-aged subjects as potential causes of midlife obesity. Specifically, the extracellular vesicles (EVs) derived from APCs display an impaired ability to mitigate the inflammaging of adipose tissue macrophages (ATMs) in middle-aged individuals. Mechanistically, these EVs, lacking miR-145-5p, fail to suppress the expression of L-selectin in ATMs, thereby facilitating their M1 program via the NF-κB signaling pathway. In contrast, EVs from young APCs effectively inhibit M1 macrophage polarization. Accordingly, targeted liposomes are designed to deliver miR-145-5p mimics to ATMs, which effectively prevent the obesity in middle-aged mice. Collectively, our findings highlight the role of APC-derived EVs in midlife obesity and propose miR-145-5pas a promising therapeutic target for clinical applications.
- Open Access
- 22 October 2024
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 24 (1) , 1-13
The association between the triglyceride-glucose index and vitamin D status: a systematic review and meta-analysis
This study aims to explore the association between the triglyceride-glucose (TyG) index and vitamin D status to enhance our understanding of how vitamin D status relates to metabolic health and to provide evidence for the early diagnosis of vitamin D deficiency (VDD) using the TyG index. We conducted a comprehensive search in various databases, including PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Biology Medicine disc, China Science and Technology Journal Database, and Wanfang Data to gather articles published from the inception of these databases until February 19, 2024. We assessed the quality of included studies using the Newcastle-Ottawa Scale (NOS) for case-control studies and the Agency for Healthcare Research and Quality (AHRQ) methodology checklist for cross-sectional studies. Statistical analyses in this study were conducted using conversion methods for non-standard data formats and consolidation techniques for combining multiple groups. The Fisher transformation method was used for correlation coefficients. We used a random-effects model considering the inherent clinical heterogeneity among the studies, and assessed statistical heterogeneity with the Cochrane Q test and I2 statistic, complemented by subgroup analyses and sensitivity analysis. Our meta-analysis selected a total of nine studies. The analysis revealed that patients with vitamin D deficiency (VDD group) exhibited a significantly higher TyG index than those without deficiency (no-VDD group), with a mean difference (MD) of 0.16 (95% CI: 0.10 to 0.23, I2 = 93%). This association was particularly pronounced among patients with type 2 diabetes (T2DM), showing an MD of 0.15 (95% CI: 0.05 to 0.26, I2 = 55%). Additionally, a negative correlation was observed between the TyG index and vitamin D levels, with a correlation coefficient (r) of -0.236 (95% CI: -0.310 to -0.159, I2 = 91%). Excluding each study sequentially in the sensitivity analyses did not significantly alter the outcomes. Our findings demonstrate a significant association between the TyG index and vitamin D status across diverse populations, including those with T2DM, subclinical hypothyroidism (SCH), and metabolic associated fatty liver disease (NAFLD). Our results reveal a notable disparity in the TyG index between vitamin D deficient and non-deficient groups, suggesting that vitamin D may play a critical role in metabolic health. These findings highlight the need for further research to explore the underlying mechanisms and clinical implications of vitamin D in the context of various metabolic disorders.
- 22 October 2024
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 24 (1) , 1-13
Open AccessThe association between the triglyceride-glucose index and vitamin D status: a systematic review and meta-analysis
This study aims to explore the association between the triglyceride-glucose (TyG) index and vitamin D status to enhance our understanding of how vitamin D status relates to metabolic health and to provide evidence for the early diagnosis of vitamin D deficiency (VDD) using the TyG index. We conducted a comprehensive search in various databases, including PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Biology Medicine disc, China Science and Technology Journal Database, and Wanfang Data to gather articles published from the inception of these databases until February 19, 2024. We assessed the quality of included studies using the Newcastle-Ottawa Scale (NOS) for case-control studies and the Agency for Healthcare Research and Quality (AHRQ) methodology checklist for cross-sectional studies. Statistical analyses in this study were conducted using conversion methods for non-standard data formats and consolidation techniques for combining multiple groups. The Fisher transformation method was used for correlation coefficients. We used a random-effects model considering the inherent clinical heterogeneity among the studies, and assessed statistical heterogeneity with the Cochrane Q test and I2 statistic, complemented by subgroup analyses and sensitivity analysis. Our meta-analysis selected a total of nine studies. The analysis revealed that patients with vitamin D deficiency (VDD group) exhibited a significantly higher TyG index than those without deficiency (no-VDD group), with a mean difference (MD) of 0.16 (95% CI: 0.10 to 0.23, I2 = 93%). This association was particularly pronounced among patients with type 2 diabetes (T2DM), showing an MD of 0.15 (95% CI: 0.05 to 0.26, I2 = 55%). Additionally, a negative correlation was observed between the TyG index and vitamin D levels, with a correlation coefficient (r) of -0.236 (95% CI: -0.310 to -0.159, I2 = 91%). Excluding each study sequentially in the sensitivity analyses did not significantly alter the outcomes. Our findings demonstrate a significant association between the TyG index and vitamin D status across diverse populations, including those with T2DM, subclinical hypothyroidism (SCH), and metabolic associated fatty liver disease (NAFLD). Our results reveal a notable disparity in the TyG index between vitamin D deficient and non-deficient groups, suggesting that vitamin D may play a critical role in metabolic health. These findings highlight the need for further research to explore the underlying mechanisms and clinical implications of vitamin D in the context of various metabolic disorders.
- 29 May 2024
- Published by Springer Nature
- p. 333-343
Fluid Mechanism Analysis of Insulin Pump Set Failure Based on Power Bond Graph
- 29 May 2024
- Published by Springer Nature
- p. 333-343
Fluid Mechanism Analysis of Insulin Pump Set Failure Based on Power Bond Graph
- 9 February 2024
- Published by Springer Nature in Acta Diabetologica
- Vol. 61 (5) , 675-678
Sintilimab-induced autoimmune diabetes mellitus manifesting as diabetic ketoacidosis in a patient with advanced esophageal squamous cell carcinoma
- 9 February 2024
- Published by Springer Nature in Acta Diabetologica
- Vol. 61 (5) , 675-678
Sintilimab-induced autoimmune diabetes mellitus manifesting as diabetic ketoacidosis in a patient with advanced esophageal squamous cell carcinoma
- Open Access
- 5 February 2024
- Published by Springer Nature in Molecular Medicine
- Vol. 30 (1) , 1-15
Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes
Background: Fluvoxamine is one of the selective serotonin reuptake inhibitors (SSRIs) that are regarded as the first-line drugs to manage mental disorders. It has been also recognized with the potential to treat inflammatory diseases and viral infection. However, the effect of fluvoxamine on autoimmune diseases, particularly type 1 diabetes (T1D) and the related cellular and molecular mechanisms, are yet to be addressed. Method: Herein in this report, we treated NOD mice with fluvoxamine for 2 weeks starting from 10-week of age to dissect the impact of fluvoxamine on the prevention of type 1 diabetes. We compared the differences of immune cells between 12-week-old control and fluvoxamine-treated mice by flow cytometry analysis. To study the mechanism involved, we extensively examined the characteristics of CD4+ T cells with fluvoxamine stimulation using RNA-seq analysis, real-time PCR, Western blot, and seahorse assay. Furthermore, we investigated the relevance of our data to human autoimmune diabetes. Result: Fluvoxamine not only delayed T1D onset, but also decreased T1D incidence. Moreover, fluvoxamine-treated NOD mice showed significantly attenuated insulitis coupled with well-preserved β cell function, and decreased Th1 and Th17 cells in the peripheral blood, pancreatic lymph nodes (PLNs), and spleen. Mechanistic studies revealed that fluvoxamine downregulated glycolytic process by inhibiting phosphatidylinositol 3-kinase (PI3K)-AKT signaling, by which it restrained effector T (Teff) cell differentiation and production of proinflammatory cytokines. Conclusion: Collectively, our study supports that fluvoxamine could be a viable therapeutic drug against autoimmunity in T1D setting.
- 5 February 2024
- Published by Springer Nature in Molecular Medicine
- Vol. 30 (1) , 1-15
Open AccessFluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes
Background: Fluvoxamine is one of the selective serotonin reuptake inhibitors (SSRIs) that are regarded as the first-line drugs to manage mental disorders. It has been also recognized with the potential to treat inflammatory diseases and viral infection. However, the effect of fluvoxamine on autoimmune diseases, particularly type 1 diabetes (T1D) and the related cellular and molecular mechanisms, are yet to be addressed. Method: Herein in this report, we treated NOD mice with fluvoxamine for 2 weeks starting from 10-week of age to dissect the impact of fluvoxamine on the prevention of type 1 diabetes. We compared the differences of immune cells between 12-week-old control and fluvoxamine-treated mice by flow cytometry analysis. To study the mechanism involved, we extensively examined the characteristics of CD4+ T cells with fluvoxamine stimulation using RNA-seq analysis, real-time PCR, Western blot, and seahorse assay. Furthermore, we investigated the relevance of our data to human autoimmune diabetes. Result: Fluvoxamine not only delayed T1D onset, but also decreased T1D incidence. Moreover, fluvoxamine-treated NOD mice showed significantly attenuated insulitis coupled with well-preserved β cell function, and decreased Th1 and Th17 cells in the peripheral blood, pancreatic lymph nodes (PLNs), and spleen. Mechanistic studies revealed that fluvoxamine downregulated glycolytic process by inhibiting phosphatidylinositol 3-kinase (PI3K)-AKT signaling, by which it restrained effector T (Teff) cell differentiation and production of proinflammatory cytokines. Conclusion: Collectively, our study supports that fluvoxamine could be a viable therapeutic drug against autoimmunity in T1D setting.